Nat. Rev. Endocrinol. doi: /nrendo

Slides:



Advertisements
Similar presentations
Cholesterol synthesis and breakdown Dr. Carolyn K. Suzuki 1.
Advertisements

Cholesterol Metabolism Cardiovascular Block. Overview Introduction Cholesterol structure Cholesteryl esters Cholesterol synthesis Rate limiting step Regulation.
Cholesterol Metabolism
Lipid Homeostasis and Transport CH353 February 12, 2008.
4-1 Protein Synthesis Is a Major Function of Cells.
Regulation of glucose levels in the blood is very important Normal Fasting (Serum) ~ 70 – 100 mg/dl Elevated = Diabetes Low = Hypoglycemia Insulin from.
Suppl 4A Large black circles: query genes
MYC, Metabolism and Cancer
by Rogelio Zamilpa, and Merry L. Lindsey
Figure 6 Cholesterol metabolism in obesity-related glomerulopathy
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
GENE REGULATION Key control mechanism for dictating cell phenotype
Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle
Figure 2 The unfolded protein response
Figure 5 Sterol regulatory element-binding
Volume 47, Issue 1, Pages (July 2007)
The Incretins and β-Cell Health: Contrasting Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 as a Path to Understand Islet Function.
Figure 2 Candidate signalling pathways of irisin in myocytess
Volume 142, Issue 6, Pages (May 2012)
Leptin and insulin signalling pathways in the Arc.
Figure 1 mTOR pathway activation
Figure 3 Candidate signalling pathways of irisin in hepatocytes
Figure 1 A schematic representation of the HER2 signalling pathway
Figure 2 Oestrogen receptor signalling pathways
Figure 2 Intracellular actions of metformin
Figure 1 Control of hepatic gluconeogenesis
Figure 2 Control of hepatic glycogen metabolism
Figure 3 Physiological regulation of autophagy in the heart
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 mTOR complex biology
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
Volume 148, Issue 7, Pages (June 2015)
Is REDD1 a Metabolic Éminence Grise?
Guido T. Bommer, Ormond A. MacDougald  Cell Metabolism 
Figure 1 The insulin signalling pathway
Rapamycin: One Drug, Many Effects
Figure 1 Regulation of hepatic glucose metabolism by the gut, brain and liver Figure 1 | Regulation of hepatic glucose metabolism by the gut, brain and.
FGFR Signaling as a Target for Lung Cancer Therapy
Cristoforo Silvestri, Vincenzo Di Marzo  Cell Metabolism 
mTORC1 signalling links cellular growth with autophagy
Autophagy in kidney disease and aging: lessons from rodent models
An Emerging Role of mTOR in Lipid Biosynthesis
Metabolic Control of Autophagy
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Selective Insulin and Leptin Resistance in Metabolic Disorders
Nat. Rev. Endocrinol. doi: /nrendo
Tyrosinase: A Central Regulatory Protein for Cutaneous Pigmentation
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
AKT/PKB Signaling: Navigating the Network
Figure 1 The mTOR signalling pathway
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Volume 93, Issue 5, Pages (March 2017)
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
A Ceramide-Centric View of Insulin Resistance
Rapamycin: One Drug, Many Effects
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Nat. Rev. Endocrinol. doi: /nrendo
Figure 4 Bile-acid-induced TGR5 signalling pathways in macrophages
mTOR and Akt Signaling in Cancer: SGK Cycles In
Metabolic Regulation by p53 Family Members
Statins Molecular mechanisms of action SREBP feedback control
Cholesterol Metabolism
Jinhua Tang, Na Liu, Shougang Zhuang  Kidney International 
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
The Salt-Inducible Kinases: Emerging Metabolic Regulators
Figure 1 Thyroid hormone effects on hepatic lipid metabolism
The multifaceted role of mTORC1 in the control of lipid metabolism
Nutrient Sensing, Metabolism, and Cell Growth Control
Connections between insulin/insulin-like growth factor 1 signaling and metabolic pathways in tumor cells. Connections between insulin/insulin-like growth.
Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2017.91 Figure 3 Nutritional and growth signalling to sterol regulatory element-binding proteins Figure 3 | Nutritional and growth signalling to sterol regulatory element-binding proteins. Anabolic states activate sterol regulatory element-binding protein (SREBP)-mediated lipogenesis. As nutritional and growth signals, insulin and growth factors such as epidermal growth factor (EGF) signal via the PI3K–AKT pathway and further link to the mechanistic target of rapamycin (mTOR) pathway, which leads to SREBP activation. AKT is also phosphorylated and activated by mTOR complex 2 (mTORC2). Many branches of the PI3K–AKT–mTORC1 pathway link to SREBP activation or regulatory processes, which include transcription of SREBP genes (SREBF); SREBP mRNA stability; translation to a SREBP precursor form in the endoplasmic reticulum (ER); retention by insulin-induced gene proteins (INSIGs); translocation of SREBPs to the Golgi membrane escorted by SREBP cleavage-activating protein (SCAP) via COPII vesicle proteins; cleavage into active SREBPs by site 1 protease (SIP) and S2P at the Golgi membrane and, ultimately, nuclear entry and binding and transactivation of target gene promoters. mTORC1 functions as the metabolic integrator of nutritional, energy and redox states by regulating protein synthesis. mTOR signalling branches to SREBP1 and lipogenesis via ribosomal protein S6 kinase (S6K), phosphatidate phosphatase lipin-1, CREB-regulated transcription coactivator 2 (CRTC2) and E4 promoter-binding protein 4 (E4BP4). Amino acids and energy hub molecules also influence mTOR–SREBP pathways. Other nutrients, liver X receptor (LXR) and atypical protein kinase C (PKC) isoforms (λ, ζ and β) activate the SREBP1c promoter for nutritional regulation. Signals involved in energy depletion, such as cAMP–protein kinase A (PKA), 5′-AMP-activated protein kinase (AMPK) and sirtuins, generally inhibit SREBP1c expression. Polyunsaturated fatty acids (PUFAs) suppress SREBP1c at multiple levels including its expression and cleavage. Black arrowsand T-bars denote stimulatory and inhibitory actions, respectively. Shimano, H. & Sato, R. (2017) SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology Nat. Rev. Endocrinol. doi:10.1038/nrendo.2017.91